Health Catalyst, Inc. (HCAT) - Q2 2026 10-Q Summary
Business Context and Reporting Period
This Quarterly Report on Form 10-Q covers the period ended June 30, 2026. Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The company operates two segments: Technology and Professional Services. The reporting period is characterized by significant strategic restructuring, including the "Project Nexus" initiative, the divestiture of the Vitalware business, and the migration of clients from the legacy DOS platform to the new "Ignite" platform.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2026 | Six Months Ended June 30, 2026 |
|---|---|---|
| Total Revenue | $70.5 million | $141.2 million |
| Net Loss | $(40.5) million | $(151.6) million |
| Net Loss Per Share (Basic & Diluted) | $(0.55) | $(2.07) |
| Adjusted EBITDA | $9.9 million | $19.1 million |
| Cash and Cash Equivalents | $60.6 million | $60.6 million (as of period end) |
| Short-term Investments | $42.9 million | $42.9 million (as of period end) |
| Total Debt (Principal) | $159.9 million | $159.9 million (as of period end) |
| Operating Cash Flow (6 months) | $18.8 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 13% year-over-year for the quarter and 12% for the six-month period. This was driven by elevated churn and down-selling related to the migration from the DOS platform to Ignite, as well as the exit of lower-margin Tech-Enabled Managed Services (TEMS) arrangements.
- Goodwill Impairment: The company recorded a significant non-cash goodwill impairment charge of $122.5 million for the six months ended June 30, 2026 (compared to $28.8 million in the prior year). This was triggered by declines in stock price, market capitalization, and the classification of the Vitalware business as "held for sale."
- Restructuring Costs: The company incurred $3.7 million in restructuring costs for the quarter and $5.5 million for the six months, primarily related to "Project Nexus" and prior workforce reduction plans.
- Operating Expenses: General and administrative expenses increased 44% year-over-year for the quarter, largely due to the absence of a $5.2 million benefit from a decrease in the fair value of contingent consideration liabilities in the prior year.
Guidance, Outlook, and Management Commentary
- Strategic Transformation (Project Nexus): Management is executing a strategic initiative to transform the operating model, simplify the organization, and align resources with high-conviction technology opportunities. This includes the divestiture of the Vitalware business.
- Vitalware Transaction: On July 31, 2026 (subsequent to the reporting period), the company closed the sale of the Vitalware business for a base purchase price of $147 million. Proceeds were used to fully repay the company's Credit Agreement ($160 million principal), eliminating interest expense but resulting in an expected loss on debt extinguishment of approximately $10 million.
- Migration Challenges: The company expects continued revenue pressure and margin compression in the near term due to the migration of clients from DOS to Ignite. Approximately $52 million of Annual Recurring Revenue (ARR) is estimated to be at risk across 2026 and 2027, though management expects to be through the churn pressure by the end of 2027.
- Macroeconomic Risks: Management cites ongoing challenges including high inflation, interest rates, and potential cuts to Medicaid and research funding (referencing the "One Big Beautiful Bill Act") as factors elongating sales cycles and straining client budgets.
- Outlook: While near-term results are impacted by restructuring and migration costs, management expects Adjusted EBITDA to improve in the long term, excluding the impact of the Vitalware divestiture.
Investor Verification Checklist
- Goodwill Impairment Drivers: Verify the specific assumptions used in the fair value assessment of the Technology reporting unit that led to the $122.5 million impairment charge.
- Vitalware Closing Details: Confirm the final purchase price adjustments and the exact timing of the gain on sale recognition (expected in Q3 2026) and the loss on debt extinguishment.
- Migration Metrics: Monitor the actual churn and down-sell rates associated with the DOS-to-Ignite migration against the $52 million at-risk ARR estimate.
- Debt Status: Confirm the full repayment of the Credit Agreement and the release of liens as a subsequent event, and assess the impact on future interest expense.
- Restructuring Progress: Track the execution of "Project Nexus" and the realization of expected cost savings versus the incurred severance and advisory costs.